United States · FDA National Drug Code directory
OLOPATADINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72657-168_bc82a9d3-2fd3-4a7d-9126-c0f07a610b05
- Product NDC
- 72657-168
- Form
- SOLUTION
- Composition / generic term
- Olopatadine Hydrochloride ophthalmic
- Labeler
- GLENMARK THERAPEUTICS INC., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240726
- Source listing expiry
- 20271231
Source-listed ingredients
- OLOPATADINE HYDROCHLORIDE — 1 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (72657-168-50) / 5 mL in 1 BOTTLE, PLASTIC · 72657-168-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →